These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 8161727)

  • 1. Effect of recombinant erythropoietin on hospital admissions, readmissions, length of stay, and costs of dialysis patients.
    Powe NR; Griffiths RI; Watson AJ; Anderson GF; de Lissovoy G; Greer JW; Herbert RJ; Milam RA; Whelton PK
    J Am Soc Nephrol; 1994 Jan; 4(7):1455-65. PubMed ID: 8161727
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medicare payment policy and recombinant erythropoietin prescribing for dialysis patients.
    Powe NR; Griffiths RI; Anderson GF; de Lissovoy G; Watson AJ; Greer JW; Herbert RJ; Whelton PK
    Am J Kidney Dis; 1993 Oct; 22(4):557-67. PubMed ID: 8213796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of insurance status on use of recombinant erythropoietin therapy among end-stage renal disease patients in three states.
    Thamer M; Richard C; Ray NF; Greer JW; Cotter DJ; Pearson BC
    Am J Kidney Dis; 1996 Aug; 28(2):235-49. PubMed ID: 8768919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Access to recombinant erythropoietin by Medicare-entitled dialysis patients in the first year after FDA approval.
    Powe NR; Griffiths RI; de Lissovoy G; Anderson GF; Watson AJ; Greer JW; Herbert RJ; Eggers PW; Milam RA; Whelton PK
    JAMA; 1992 Sep; 268(11):1434-40. PubMed ID: 1512912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of recombinant human erythropoietin usage in clinical practice in the United States. Is there an optimal way to use rHuEPO?
    Besarab A; McCrea JB
    ASAIO J; 1993; 39(1):11-8. PubMed ID: 8439674
    [No Abstract]   [Full Text] [Related]  

  • 7. A review of the first year of Medicare coverage of erythropoietin.
    Griffiths RI; Powe NR; Greer J; de Lissovoy G; Anderson GF; Whelton PK; Watson AJ; Eggers PW
    Health Care Financ Rev; 1994; 15(3):83-102. PubMed ID: 10137799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost implications to Medicare of recombinant erythropoietin therapy for the anemia of end-stage renal disease.
    Powe NR; Griffiths RI; Bass EB
    J Am Soc Nephrol; 1993 Apr; 3(10):1660-71. PubMed ID: 8318682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant erythropoietin and Medicare payment.
    Sisk JE; Gianfrancesco FD; Coster JM
    JAMA; 1991 Jul; 266(2):247-52. PubMed ID: 2056627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secular trends in recombinant erythropoietin therapy among the U.S. hemodialysis population: 1990-1996.
    Cotter DJ; Thamer M; Kimmel PL; Sadler JH
    Kidney Int; 1998 Dec; 54(6):2129-39. PubMed ID: 9853279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients.
    Cheng IK; Lu HB; Wei DC; Cheng SW; Chan CY; Lee FC
    Am J Nephrol; 1993; 13(2):142-8. PubMed ID: 8342581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does One Size Fit All With the Effects of Payment Reform? Dialysis Facility Payer Mix and Anemia Management Under the Expanded Medicare Prospective Payment System.
    Mukhopadhyay P; Pearson J; Cogan C; Gaber C; Gillespie BW; Turenne M
    Med Care; 2019 Aug; 57(8):584-591. PubMed ID: 31295188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the prospective payment system on anemia management in maintenance dialysis patients: implications for cost and site of care.
    Wetmore JB; Tzivelekis S; Collins AJ; Solid CA
    BMC Nephrol; 2016 May; 17(1):53. PubMed ID: 27228981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Financial implications to Medicare from changing the dialysis modality mix under the bundled prospective payment system.
    Liu FX; Walton SM; Leipold R; Isbell D; Golper TA
    Perit Dial Int; 2014; 34(7):749-57. PubMed ID: 25292402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Inpatient Palliative Care with Health Care Utilization and Postdischarge Outcomes among Medicare Beneficiaries with End Stage Kidney Disease.
    Chettiar A; Montez-Rath M; Liu S; Hall YN; O'Hare AM; Kurella Tamura M
    Clin J Am Soc Nephrol; 2018 Aug; 13(8):1180-1187. PubMed ID: 30026286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Costs of chronic dialysis in a public hospital: myths and realities].
    Lamas J; Alonso M; Saavedra J; García-Trío G; Rionda M; Ameijeiras M
    Nefrologia; 2001; 21(3):283-94. PubMed ID: 11471309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of pure red cell aplasia in US dialysis patients: the limits of the Medicare data.
    Collins AJ; Li S; Adamson JW; Gilbertson DT
    Am J Kidney Dis; 2004 Mar; 43(3):464-70. PubMed ID: 14981604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anemia in peritoneal dialysis patients].
    Lausević M; Nesić V; Jovanović N; Stojimirović B
    Srp Arh Celok Lek; 2006; 134(3-4):133-7. PubMed ID: 16915754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of human recombinant erythropoietin on anaemia and dialysis efficiency in patients undergoing continuous ambulatory peritoneal dialysis.
    Steinhauer HB; Lubrich-Birkner I; Dreyling KW; Schollmeyer P
    Eur J Clin Invest; 1991 Feb; 21(1):47-52. PubMed ID: 1907554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the Comprehensive End-Stage Renal Disease Care Model With Medicare Payments and Quality of Care for Beneficiaries With End-Stage Renal Disease.
    Marrufo G; Colligan EM; Negrusa B; Ullman D; Messana J; Shah A; Duvall T; Hirth RA
    JAMA Intern Med; 2020 Jun; 180(6):852-860. PubMed ID: 32227133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.